2022, Number 1
Diabetic macroangiopathy and stem cell autotransplantation
Language: Spanish
References: 15
Page: 1-14
PDF size: 508.14 Kb.
ABSTRACT
Introduction: the therapeutic potential of stem cells in the treatment of peripheral arteriopathy is evident.Objective: to assess the safety and efficacy of the procedure in diabetic macroangiopathy.
Methods: an observational, prospective and longitudinal study, which included 50 patients. They were monitored for 12 months with blood pressure index, claudication distance and pain assessment. The analysis was based on the determination of mean values, percentile values and the application of proportions and Duncan's test.
Results: male patients and the age group from 60-70 years old predominated. In the first month of treatment, pain and claudication distance improved significantly. No adverse side effects were observed in any case.
Conclusions: the procedure was effective and without complications, which encourages the continuation of clinical studies in this field.
REFERENCES
OPS. Asociación Latinoamericana de Diabetes. Guías ALAD sobre el Diagnóstico, Control y Tratamiento de la Diabetes Mellitus Tipo 2 con Medicina Basada en Evidencia [Internet]. OPS. ALAD; 2010 [Citado 20/07/2020]. Disponible en: Disponible en: https://www.paho.org/hq/index.php?option=com_content&view=article&id=2164:2010-guias-alad-diagnostico-control-tratamiento-diabetes-mellitus-tipo-2&Itemid=39447&lang=es
Piepoli MF, Scheinert D, Sievert H, Simpson I, Sulzenko J, Tamargo J; Task Force Members. ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg [Internet]. 2018 [Citado 20/07/2020]; 55(3): 305-368. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S1078588417304549?via%3Dihub
Lanza RP, Chung HY, Yoo JJ, Wettstein PJ, Blackwell C & Borson N. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol [Internet]. 2002 [Citado 20/07/2020]; 20(7): 689-96. Disponible en: Disponible en: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.485.5773&rep=rep1&type=pdf
de la Torre Puente C, Triana Mantilla ME, Rodríguez Villalonga LE, Arpajón Peña Y, Almeida Hernández L, Martínez Góngora I. Enfermedades vasculares periféricas y niveles de calidad de vida en el municipio Diez de Octubre. Rev Cubana Angiol Cir Vasc [Internet]. 2017 Jun [citado 10/09/2020]; 18(1): 55-70. Disponible en: Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1682-00372017000100006&lng=es
Salgado Castillo I, Triana Mantilla ME, Rodríguez Villalonga LE, Arpajón Peña Y. Prevalencia de enfermedades vasculares periféricas en el municipio de Arroyo Naranjo. Rev Cubana Angiol Cir Vasc [Internet]. 2016 [citado 10/09/2020]; 17(2): 138-149. Disponible en: Disponible en: http://scielo.sld.cu/pdf/ang/v17n2/ang04216.pdf
Kirana S, Stratmann B, Prante C, Prohaska W, Koerperich H,Lammers D, et al. Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patient. Int J Clin Pract [Internet]. 2012 [citado 10/09/2020]; 66(4):384-93. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/22284892/
Hernández Ramírez P, Alfonso Simón A, Aparicio Suárez JL, Artaza Sanz H, Baganet Cobas A, Blanco Díaz Á, et al. Experiencia cubana con el uso terapéutico de células madre adultas. Rev Cubana Hematol Inmunol Hemoter [Internet]. Mar 2011 [citado 24/11/2016]; 27(1). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892011000100012&lng=es
Martínez Garrido R, Montano Iglesias E, de Armas López G, Pérez Montiel D. Aplicación de la terapia regenerativa en la enfermedad arterial periférica y el pie diabético isquémico. Rev Cubana Angiol Cir Vasc [Internet]. 2019 Dic [citado 02/07/2020]; 20(2): 389. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1682-00372019000200004&lng=es